4.5 Article

Expression analysis of the early chemokine response 4 h after in vitro traumatic brain injury

Related references

Note: Only part of the references are listed.
Article Neurosciences

Appearance of Cxcl10-expressing cell clusters is common for traumatic brain injury and neurodegenerative disorders

Charlotte Israelsson et al.

EUROPEAN JOURNAL OF NEUROSCIENCE (2010)

Article Endocrinology & Metabolism

Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice

Bridgette D. Semple et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)

Article Critical Care Medicine

Propofol: neuroprotection in an in vitro model of traumatic brain injury

Jan Rossaint et al.

CRITICAL CARE (2009)

Article Critical Care Medicine

Argon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury

Philip D. Loetscher et al.

CRITICAL CARE (2009)

Article Critical Care Medicine

The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury

Mark Coburn et al.

CRITICAL CARE MEDICINE (2008)

Article Clinical Neurology

Chemokine detection in the cerebral tissue of patients with posttraumatic brain contusions

Roberto Stefini et al.

JOURNAL OF NEUROSURGERY (2008)

Article Critical Care Medicine

Plasma levels of the beta chemokine regulated upon activation, normal T cell expressed, and secreted (RANTES) correlate with severe brain injury

Kimberly Lumpkins et al.

JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2008)

Review Critical Care Medicine

Modulation of immune response by head injury

Maria Cristina Morganti-Kossmann et al.

INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED (2007)

Review Anesthesiology

Pathophysiology of traumatic brain injury

C. Werner et al.

BRITISH JOURNAL OF ANAESTHESIA (2007)

Article Biochemical Research Methods

Methods to induce primary and secondary traumatic damage in organotypic hippocampal slice cultures

Y Adamchik et al.

BRAIN RESEARCH PROTOCOLS (2000)